FDA — authorised 16 October 2015
- Application: NDA207589
- Marketing authorisation holder: LEO PHARMA AS
- Local brand name: ENSTILAR
- Indication: AEROSOL, FOAM — TOPICAL
- Status: approved
🇺🇸 Calcipotriene and betamethasone dipropionate ointment in United States
FDA authorised Calcipotriene and betamethasone dipropionate ointment on 16 October 2015
Marketing authorisation
Other Dermatology approved in United States
Frequently asked questions
Is Calcipotriene and betamethasone dipropionate ointment approved in United States?
Yes. FDA authorised it on 16 October 2015.
Who is the marketing authorisation holder for Calcipotriene and betamethasone dipropionate ointment in United States?
LEO PHARMA AS holds the US marketing authorisation.